Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy R Watkins

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Advances in Therapy|May 25, 2022
MANTA and MANTA-RAy: Rationale and Design of Trials Evaluating Effects of Filgotinib on Semen Parameters in Patients with Inflammatory DiseasesWayne J G Hellstrom, Radboud J E M Dolhain, Timothy E Ritter, et al.
ERJ Open Research|February 18, 2026
Prognostic biomarkers for idiopathic pulmonary fibrosis: findings from ISABELA clinical trialsMatthew J Randall, Claus A Andersen, Kevin K Brown, et al.
Annals of the Rheumatic Diseases|May 3, 2023
Effects of filgotinib on semen parameters and sex hormones in male patients with inflammatory diseases: results from the phase 2, randomised, double-blind, placebo-controlled MANTA and MANTA-RAy studiesWalter Reinisch, Wayne Hellstrom, Radboud J E M Dolhain, et al.
Clinical and Translational Gastroenterology|July 8, 2024
Cilofexor in Patients With Compensated Cirrhosis Due to Primary Sclerosing Cholangitis: An Open-Label Phase 1B StudyCynthia Levy, Stephen Caldwell, Parvez Mantry, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 24, 2023
A randomized controlled trial of presatovir for respiratory syncytial virus after lung transplantJens Gottlieb, Fernando Torres, Tarik Haddad, et al.
JAMA Ophthalmology|July 18, 2024
Filgotinib in Active Noninfectious Uveitis: The HUMBOLDT Randomized Clinical TrialSunil K Srivastava, Timothy R Watkins, Quan Dong Nguyen, et al.
Critical Care Medicine|March 23, 2011
A phase II randomized placebo-controlled trial of omega-3 fatty acids for the treatment of acute lung injuryRenee D Stapleton, Thomas R Martin, Noel S Weiss, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 10, 2020
A Phase 2b, Randomized, Double-blind, Placebo-Controlled Multicenter Study Evaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability of Presatovir in Hematopoietic Cell Transplant Recipients with Respiratory Syncytial Virus Infection of the Lower Respiratory TractFrancisco M Marty, Roy F Chemaly, Kathleen M Mullane, et al.
American Journal of Respiratory and Critical Care Medicine|August 31, 2010
Early identification of patients at risk of acute lung injury: evaluation of lung injury prediction score in a multicenter cohort studyOgnjen Gajic, Ousama Dabbagh, Pauline K Park, et al.
JAMA|May 9, 2023
Ziritaxestat, a Novel Autotaxin Inhibitor, and Lung Function in Idiopathic Pulmonary Fibrosis: The ISABELA 1 and 2 Randomized Clinical TrialsToby M Maher, Paul Ford, Kevin K Brown, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Advances in Therapy|May 25, 2022
MANTA and MANTA-RAy: Rationale and Design of Trials Evaluating Effects of Filgotinib on Semen Parameters in Patients with Inflammatory DiseasesWayne J G Hellstrom, Radboud J E M Dolhain, Timothy E Ritter, et al.
ERJ Open Research|February 18, 2026
Prognostic biomarkers for idiopathic pulmonary fibrosis: findings from ISABELA clinical trialsMatthew J Randall, Claus A Andersen, Kevin K Brown, et al.
Annals of the Rheumatic Diseases|May 3, 2023
Effects of filgotinib on semen parameters and sex hormones in male patients with inflammatory diseases: results from the phase 2, randomised, double-blind, placebo-controlled MANTA and MANTA-RAy studiesWalter Reinisch, Wayne Hellstrom, Radboud J E M Dolhain, et al.
Clinical and Translational Gastroenterology|July 8, 2024
Cilofexor in Patients With Compensated Cirrhosis Due to Primary Sclerosing Cholangitis: An Open-Label Phase 1B StudyCynthia Levy, Stephen Caldwell, Parvez Mantry, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 24, 2023
A randomized controlled trial of presatovir for respiratory syncytial virus after lung transplantJens Gottlieb, Fernando Torres, Tarik Haddad, et al.
JAMA Ophthalmology|July 18, 2024
Filgotinib in Active Noninfectious Uveitis: The HUMBOLDT Randomized Clinical TrialSunil K Srivastava, Timothy R Watkins, Quan Dong Nguyen, et al.
Critical Care Medicine|March 23, 2011
A phase II randomized placebo-controlled trial of omega-3 fatty acids for the treatment of acute lung injuryRenee D Stapleton, Thomas R Martin, Noel S Weiss, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 10, 2020
A Phase 2b, Randomized, Double-blind, Placebo-Controlled Multicenter Study Evaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability of Presatovir in Hematopoietic Cell Transplant Recipients with Respiratory Syncytial Virus Infection of the Lower Respiratory TractFrancisco M Marty, Roy F Chemaly, Kathleen M Mullane, et al.
American Journal of Respiratory and Critical Care Medicine|August 31, 2010
Early identification of patients at risk of acute lung injury: evaluation of lung injury prediction score in a multicenter cohort studyOgnjen Gajic, Ousama Dabbagh, Pauline K Park, et al.
JAMA|May 9, 2023
Ziritaxestat, a Novel Autotaxin Inhibitor, and Lung Function in Idiopathic Pulmonary Fibrosis: The ISABELA 1 and 2 Randomized Clinical TrialsToby M Maher, Paul Ford, Kevin K Brown, et al.
Pageof 6